With a change in national leadership and a push for universal healthcare, the medical industry is at a crossroad. Healthcare providers and payers have a renewed interest in using technology to improve patient treatment, all while keeping a close eye to the bottom line. And healthcare companies— including major life science groups — are adapting their products accordingly — with a little help from TriStar's Surface Modification Division.

Surface modification, simplified

Surface modification is the combination of physics and chemistry working together to change materials and enhance surface properties. In medical terms, this can mean altering the surface properties of plastic to better accept drugs, or to improve biocompatibility during surgery and recovery.

Our client, a leader in the clinical translation of medical technologies, contacted us to help them modify the surface of their reel-to-reel devices used in prenatal blood filtering systems. Their devices are used to improve the exchange of carbon dioxide and oxygen, and provide a reliable means of fetal circulatory support.

Plasma, precisely

Our team employed our plasma treatment to change the surface tension of the client’s plastic materials. One clear advantage of using plasma is the enhanced control of treatment conditions relating to gas flow and pressure. With plasma, we were able to functionalize the client’s plastic surface for improved molecular adhesion.

TriStar’s Surface Modification Division is growing rapidly as industries realize the cost savings and the manufacturing and yield benefits of chemically altering plastic components. In fact, we were the first to treat PEEK and PVC materials for better acceptance of timed-release medications. To stay current on our latest innovations, we invite you to visit our blog.

To learn more about the TriStar advantage, visit us at the newly-updated tstar.com